中國醫藥大學、亞洲大學「中亞聯大」系統學校，由亞大醫學系王昭能教授、中醫大附醫醫院副院長黃秋錦、賴宇軒等團隊，共同研發「居家血液透析智能監控與預警系統」，俗稱「洗腎」，邊透析邊適度調慢透析速度、延長治療時間，讓患者能在家中進行血液透析。研究顯示，採用居家血液透析患者5年存活率，比傳統血液透析高出30至40%，為目前最理想的透析模式，榮獲國內生醫與大健康領域最高指標獎項「2024國家新創獎」，相關技術已申請台灣、美國專利。
The research team from the "China-Asia University System" (CAUS), formed by China Medical University and Asia University, led by Prof. Chao-Tung Wang from the AU Department of Medicine, alongside Vice Superintendents Chiu-Ching Huang and Yu-Hsuan Lai from China Medical University Hospital (CMUH), has jointly developed the "Intelligent Monitoring and Warning System for Home Hemodialysis" (commonly known as kidney dialysis). By appropriately slowing down the dialysis speed and extending the treatment duration during the process, this system allows patients to undergo hemodialysis safely at home. Research indicates that the 5-year survival rate of patients utilizing home hemodialysis is 30% to 40% higher than those undergoing conventional hemodialysis, making it the most ideal dialysis modality at present. This breakthrough garnered the "2024 National Innovation Award," the highest benchmark accolade in the domestic biomedical and healthcare sectors, and the related technologies have been filed for patents in Taiwan and the United States.
王昭能教授表示，台灣末期腎病的發生、盛行率高居全球第一，且持續攀升中，每年耗費健保近500億元。面對醫院公共衛生防治的挑戰，醫療大數據與人工智慧的蓬勃發展為腎臟疾病照護帶來創新契機。本次獲獎的「居家血液透析智能監控預警系統」，與中醫大附醫黃秋錦、賴宇軒、陳俊良副院長、張詩聖和郭慧亮主任、廖健伸分析師、盧雅惠護理師組成團隊，共同合作開發，透過跨領域整合，結合臨床醫師的專業與電腦科學的數位技術，成功開發出這套智能監控與預警系統，為患者創造更安全、舒適的透析環境。
Prof. Chao-Tung Wang stated that Taiwan's incidence and prevalence of end-stage renal disease (ESRD) rank first globally and continue to escalate, costing the National Health Insurance (NHI) nearly NT$50 billion annually. Facing the challenges of public health prevention and control in hospitals, the vigorous development of medical big data and artificial intelligence brings innovative opportunities for renal disease care. The award-winning "Intelligent Monitoring and Warning System for Home Hemodialysis" was collaboratively developed by a team consisting of Chiu-Ching Huang, Yu-Hsuan Lai, Vice Superintendent Jiun-Liang Chen, Directors Shih-Sheng Chang and Hui-Liang Kuo, Analyst Chien-Shin Liao, and Registered Nurse Ya-Hui Lu from CMUH. Through cross-disciplinary integration that merges the expertise of clinicians with digital computer science techniques, this intelligent monitoring and warning system was successfully forged, shaping a safer and more comfortable dialysis environment for patients.
王昭能教授指出，居家血液透析有「三好一少」優點，讓患者能吃得好、精神好、生活品質好，且服藥量明顯減少，除了提高存活率和改善健保品質外，也無需長期往返醫院，省去舟車勞頓之苦。為確保治療安全，研究團隊開發結合數位照護App、雲端照護平台的智能監控預警系統，整合透析機與物聯網數據，運用人工智慧技術預測，並識別治療過程中的潛在風險，一旦發現異常即自動通知患者、醫護人員及家屬，及時處理。目前該系統已成功監測超過1萬次以上居家血液透析療程，相關技術已申請台灣、美國專利。
Prof. Chao-Tung Wang pointed out that home hemodialysis offers the benefits of "three highs and one low"—allowing patients to eat well, feel energetic, enjoy a high quality of life, and substantially reduce their medication dosage. In addition to enhancing survival rates and refining health insurance efficiency, it liberates patients from long-term, exhausting commutes to and from hospitals. To ensure treatment safety, the research team engineered an intelligent monitoring and warning system that integrates a digital care App with a cloud-based care platform. By consolidating data from dialysis machines and the Internet of Things (IoT) and utilizing artificial intelligence to forecast and identify potential risks during treatment, the system automatically alerts patients, medical staff, and family members for timely intervention if any anomaly is detected. Currently, the system has successfully monitored over 10,000 home hemodialysis sessions, and its proprietary technologies have been filed for Taiwanese and U.S. patents.
王昭能教授說，值得一提的是，社團法人國家生技醫療產業策進會，自2003年設立「國家新創獎」，表彰在生技製藥、新醫療技術、醫療器材及設備等領域具有創新特色、技術優勢與應用策略的傑出成果。亞大在推動智慧大健康產業相關人工智慧技術方面表現卓越，近年來屢獲殊榮、傳遞佳音，未來將持續致力於智慧醫療在腎臟疾病領域的研究，進一步整合數位科技於腎臟疾病照護。
Prof. Chao-Tung Wang added that it is worth noting that the Institute for Biotechnology and Medicine Industry (IBMI) established the "National Innovation Award" in 2003 to honor outstanding achievements featuring innovative characteristics, technical advantages, and practical strategies in fields such as biopharmaceuticals, new medical technologies, and medical devices and equipment. Asia University has demonstrated stellar performance in advancing artificial intelligence technologies associated with the smart healthcare industry, repeatedly winning accolades and spreading good tidings in recent years. Looking ahead, the university will remain dedicated to smart medical research within the domain of kidney diseases, further integrating digital technology into renal disease care.